Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Dimick, J. Stanley, D. Axelrod, A. Kazmers, P. Henke, L. Jacobs, T. Wakefield, L. Greenfield, G. Upchurch (2002)
Variation in Death Rate After Abdominal Aortic Aneurysmectomy in the United States: Impact of Hospital Volume, Gender, and AgeAnnals of Surgery, 235
I. Rapchuk, Shannon Rabuka, M. Tonelli (2004)
Perioperative use of beta-blockers remains low: Experience of a single Canadian tertiary institutionCanadian Journal of Anesthesia, 51
A. Prasad, R. Mincemoyer, A. Quyyumi (2001)
Anti-ischemic effects of angiotensin- converting enzyme inhibition in hypertension.Journal of the American College of Cardiology, 38 4
Y. Sasaki, F. Isobe, S. Kinugasa, K. Iwata, T. Murakami, Motoko Saito, M. Motoki (2004)
Influence of Coronary Artery Disease on Operative Mortality and Long-Term Survival After Abdominal Aortic Aneurysm RepairSurgery Today, 34
S. Hert, L. Foubert, Jan Poelaert, C. Verborgh, Dirk Vlasselaers, P. Wouters (2003)
Beta-adrenergic blocking drugs in the perioperative period.Acta anaesthesiologica Belgica, 54 2
H. Alber, J. Dulak, M. Frick, W. Dichtl, S. Schwarzacher, O. Pachinger, F. Weidinger (2002)
Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease.Journal of the American College of Cardiology, 39 12
D. Poldermans, E. Boersma, Jeroen Bax, I. Thomson, L. Ven, J. Blankensteijn, H. Baars, T. Yo, G. Trocino, C. Vigna, J. Roelandt, H. Urk (1999)
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.The New England journal of medicine, 341 24
I Rapchuk, S Rabuka, M Tonelli (2004)
Perioperative use of beta-blockers remains low: experience of a single Canadian tertiary institutionCan J Anaesth, 51
D. Hackam, Sonia Anand, S. Yusuf (2003)
Oral Anticoagulant Therapy in Patients with Coronary Artery DiseaseSEMINARS IN VASCULAR MEDICINE, 03
Huyen Tran, Sonia Anand (2004)
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.JAMA, 292 15
E. Vandenkerkhof, B. Milne, J. Parlow (2003)
Knowledge and Practice Regarding Prophylactic Perioperative Beta Blockade in Patients Undergoing Noncardiac Surgery: A Survey of Canadian AnesthesiologistsAnesthesia & Analgesia, 96
Murat Bayazit, M. Göl, B. Battaloglu, H. Tokmakoǧlu, O. Taşdemír, K. Bayazit (1995)
Routine coronary arteriography before abdominal aortic aneurysm repair.American journal of surgery, 170 3
J. Shammash, J. Trost, J. Gold, J. Berlin, M. Golden, S. Kimmel (2001)
Perioperative β-blocker withdrawal and mortality in vascular surgical patientsAmerican Heart Journal, 141
L. Kjøller-Hansen, R. Steffensen, P. Grande (2000)
The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES).Journal of the American College of Cardiology, 35 4
C. Hennekens, M. Dyken, V. Fuster (1997)
Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association.Circulation, 96 8
S. Mukai, H. Yao, T. Miyamoto, M. Yamamura, T. Nakagawa, M. Ryomoto (2002)
The long-term follow-up results of elective surgical treatment for abdominal aortic aneurysms.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 8 1
I. Evers, H. Valk, Gerard Visser (2004)
Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the NetherlandsBMJ : British Medical Journal, 328
D. Mangano, E. Layug, A. Wallace, I. Tateo (1996)
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.The New England journal of medicine, 335 23
R. Harrington, R. Becker, M. Ezekowitz, T. Meade, C. O'connor, D. Vorchheimer, G. Guyatt (2004)
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest, 126 3 Suppl
N. Brown, D. Vaughan (1998)
Angiotensin-converting enzyme inhibitors.Circulation, 97 14
PK Lindenauer, P Pekow, K Wang (2004)
Lipid-lowering therapy and in-hospital mortality following major noncardiac surgeryJAMA, 291
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais (2000)
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.The New England journal of medicine, 342 3
D. Poldermans, Jeroen Bax, M. Kertai, B. Krenning, C. Westerhout, A. Schinkel, I. Thomson, P. Lansberg, L. Fleisher, J. Klein, H. Urk, J. Roelandt, E. Boersma (2003)
Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular SurgeryCirculation: Journal of the American Heart Association, 107
P. Devereaux, S. Yusuf, Homer Yang, P. Choi, G. Guyatt (2004)
Are the recommendations to use perioperative β-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence?Canadian Medical Association Journal, 171
D. Neilipovitz, G. Bryson, G. Nichol (2001)
The Effect of Perioperative Aspirin Therapy in Peripheral Vascular Surgery: A Decision AnalysisAnesthesia & Analgesia, 93
E. Dillavou, S. Muluk, M. Makaroun (2006)
Improving aneurysm-related outcomes: nationwide benefits of endovascular repair.Journal of vascular surgery, 43 3
L. Kjøller-Hansen, R. Steffensen, P. Grande (1998)
The Angiotensin Converting Enzyme Inhibition Post Revascularization Study (APRES). Effects of ramipril in patients with reduced left ventricular function. Rationale, design, methods, baseline characteristics and first-year experience.Scandinavian cardiovascular journal : SCJ, 32 4
S Yusuf, P Sleight, J Pogue (2000)
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study investigatorsN Engl J Med, 342
P. Sleight, S. Yusuf (2003)
New evidence on the importance of the renin–angiotensin system in the treatment of higher-risk patients with hypertensionJournal of Hypertension, 21
M. Eisenberg, Karen Okrainec, J. Lefkovits, E. Goudreau, U. Deligonul, K. Mak, R. Duerr, Janius Tsang, T. Huynh, S. Sedlis, David Brown, D. Brieger, L. Pilote (2003)
Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.The Canadian journal of cardiology, 19 9
P. Lindenauer, P. Pekow, Kaijun Wang, D. Mamidi, B. Gutierrez, Evan Benjamin (2005)
Perioperative beta-blocker therapy and mortality after major noncardiac surgery.The New England journal of medicine, 353 4
J. Muhlestein (2000)
Post-hospitalization Management of High-Risk Coronary PatientsAmerican Journal of Cardiology, 85
Open abdominal aortic aneurysm (AAA) repair is a common surgical procedure associated with high mortality rates. Our objective was to describe the use of in-hospital cardiac medical therapy among patients undergoing open AAA repair and to examine the effect of perioperative cardiac medical therapy on in-hospital mortality. We examined clinical data and in-hospital medication use among 223 patients who underwent open AAA repair at three North American hospitals, all of which used the Transition resource and cost accounting system. Medication use was described [angiotensin converting enzyme (ACE) inhibitors, aspirin, ß-blockers, and statins] within the cohort at five specific periods of time: presurgery, day of surgery, 1 day after surgery, postsurgery, and discharge. We then performed a matched case-control study where cases were defined as patients who died in-hospital. We compared medication use between cases and controls to assess its impact on in-hospital mortality. Most patients were elderly (mean age 72.5 ± 9.8 years), 70.4% were male, and in-hospital mortality within the cohort was 10.8%. Medication use in all periods of administration was low. ß-Blocker use was highest among all classes on the day of surgery, with 20.6% of patients undergoing AAA repair receiving the medication. Less than 50% of patients received any of the medications at discharge. After adjusting for baseline differences, perioperative ACE inhibitor use showed a trend toward a protective effect [odds ratio (OR) = 0.09, 95% confidence interval (CI) 0.01-1.31, p = 0.08], and perioperative ß-blocker use was significantly associated with a decrease in mortality (OR = 0.07, 95% CI 0.01-0.87, p = 0.04). Cardiac medical therapy among patients undergoing AAA repair is low throughout all periods of hospitalization. ACE inhibitor and ß-blocker use may be associated with decreased in-hospital mortality.
Annals of Vascular Surgery – Springer Journals
Published: Jun 23, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.